Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Luteinizing Hormone Supplementation in Controlled Ovarian Stimulation: The Iran Delphi Consensus Publisher



S Salehpour SAGHAR ; A Alleyassin ASHRAF ; A Moini ASHRAF ; N Mousavifar NEZHAT ; N Mohammadhossein NASRESFAHANI ; S Abdollahifard SEDIGHEH ; S Marzie SANUIEFARIMANI ; M Mohammadzadeh MAHBOUBEH ; R Fischer ROBERT
Authors

Source: Frontiers in Reproductive Health Published:2024


Abstract

Introduction: Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity. Methods: Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements. Results: Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3′) obtained an 83% agreement. Discussion: The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Fixed Versus Flexible Antagonist Protocol in Reduced Ovarian Reserve Patients: A Historical Cohort Study, International Journal of Women's Health and Reproduction Sciences (2019)
2. Nrh Agonists Stop Antagonist Protocol Versus Gnrh Antagonist Protocol in Poor Ovarian Responders Undergoing Ivf; [Protocolo De Antagonista De Parada De Agonista De Gnrh Versus Protocolo De Antagonista De Gnrh En Pacientes Con Respuesta De Ovario Deficiente Sometidos a Fiv], Revista Latinoamericana de Hipertension (2022)
3. Luteinizing Hormone Changes in Gonadotropin-Releasing Hormone Antagonist Protocol in in Vitro Fertilization Cycles: A Cross-Sectional Study, International Journal of Reproductive BioMedicine (2019)
Experts (# of related papers)
View all Related Experts
Ladan Kashani (4)
Maryam Farid Mojtahedi (4)
Other Related Docs
4. Optimal Cutoff Value of Basal Anti-Mullerian Hormone in Iranian Infertile Women for Prediction of Ovarian Hyper-Stimulation Syndrome and Poor Response to Stimulation Female Fertility, Reproductive Health (2015)
5. Growth Hormone (Gh) Improvement of Ovarian Responses and Pregnancy Outcome in Poor Ovarian Responders: A Randomized Study, Asian Pacific Journal of Cancer Prevention (2019)
6. Low-Dose Hcg As Trigger Day and 35 Hr Later Have Different Ovarian Hyperstimulation Syndrome Occurrence in Females Undergoing in Vitro Fertilization: An Rct, International Journal of Reproductive BioMedicine (2017)
7. The Association of Amh Level With the Number and Quality of Oocytes in Women Undergoing Ivf/Icsi: A Single-Center Study, Journal of Reproduction and Infertility (2024)
8. Letrozole+ Gnrh Antagonist Stimulation Protocol in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection Cycles: An Rct, International Journal of Reproductive BioMedicine (2017)
9. Letrozole As Co-Treatment Agent in Ovarian Stimulation Antagonist Protocol in Poor Responders: A Double-Blind Randomized Clinical Trial, International Journal of Reproductive BioMedicine (2019)
10. Early Administration of Gonadotropin-Releasing Hormone Antagonist Versus Flexible Antagonist Ovarian Stimulation Protocol in Poor Responders: A Randomized Clinical Trial, Middle East Fertility Society Journal (2021)
11. The Effect of Methyltestosterone on in Vitro Fertilization Outcomes: A Randomized Clinical Trial on Patients With Low Ovarian Response, Clinical and Experimental Reproductive Medicine (2024)
12. Analysis of Ovarian Reserve Markers (Amh, Fsh, Afc) in Different Age Strata in Ivf/Icsi Patients, International Journal of Reproductive BioMedicine (2016)
13. Oocyte Quality and in Vitro Fertilization Outcome in Triggering With Gnrh Agonist Versus Hcg, Gazzetta Medica Italiana Archivio per le Scienze Mediche (2023)
14. Gnrh Agonist Trigger Versus Hcg Trigger in Gnrh Antagonist in Ivf/Icsi Cycles: A Review Article, International Journal of Reproductive BioMedicine (2016)
15. Effects of Letrozole-Hmg and Clomiphene-Hmg on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial, Global journal of health science (2015)
16. Impact of Prolonged Versus Ocp Plus Long Protocol on Ivf-Et Outcomes in Patients With Grade Iii-Iv Endometriosis: A Randomized Clinical Trial, Acta Medica Iranica (2018)
17. Comparing a Biosimilar Follitropin Alfa (Cinnal-F®) With Gonal-F® in Women Undergoing Ovarian Stimulation: An Rct, International Journal of Reproductive BioMedicine (2021)
18. Pregnancy Outcome of “Delayed Start” Gnrh Antagonist Protocol Versus Gnrh Antagonist Protocol in Poor Responders: A Clinical Trial Study, International Journal of Reproductive BioMedicine (2017)
19. Controlled Ovarian Stimulation With R-Fsh Plus R-Lh Vs. Hmg Plus R-Fsh in Patients Candidate for Ivf/Icsi Cycles: An Rct, International Journal of Reproductive BioMedicine (2017)
20. In Vitro Fertilization Success and Associated Factors: A Prospective Cohort Study, International Journal of Women's Health and Reproduction Sciences (2018)